高效液相色谱－电化学检测法测定人尿液中的5－羟基吲哚乙酸和高香草酸

 报道用反相高效液相色谱－电化学检测法同时测定人尿液中的５－羟基吲哚乙酸（５－ＨＩＡＡ）和高香草酸（ＨＶＡ），方法简便、快速、灵敏，尿样酸化后高心经稀释直接用于高效液相色谱（ＨＰＬＣ）分析。尿液中５－ＨＩＡＡ和ＨＶＡ的浓度在０．１２５～２０只μｇ／ｍＬ之间，回收率线性关系良好。测定了正常人和接触锰人群组尿液中的５－ＨＩＡＡ和ＨＶＡ。     

高效液相色谱－电化学检测法测定人尿液中的5－羟基吲哚乙酸和高香草酸

报道用反相高效液相色谱－电化学检测法同时测定人尿液中的５－羟基吲哚乙酸（５－ＨＩＡＡ）和高香草酸（ＨＶＡ），方法简便、快速、灵敏，尿样酸化后高心经稀释直接用于高效液相色谱（ＨＰＬＣ）分析。尿液中５－ＨＩＡＡ和ＨＶＡ的浓度在０．１２５～２０只μｇ／ｍＬ之间，回收率线性关系良好。测定了正常人和接触锰人群组尿液中的５－ＨＩＡＡ和ＨＶＡ。     

二水草酸钙的热力学转化及海藻多糖的稳定作用

草酸钙结石的形成与尿液中草酸钙的存在形式密切相关，一水草酸钙(COM)促进尿石症形成，而二水草酸钙(COD)易随尿液排出体外。本文采用体外模拟方法，比较研究了COD晶体在水溶液、正常人尿液和结石患者尿液3个不同体系中的稳定性及海藻龙须菜多糖(SPS)对COD的稳定作用。在水溶液和患者尿液中，不但COD转化率高，而且得到的转化产物COM晶体聚集程度大；而在正常人尿液中，COD转化率低，转化产物聚集程度较小。COD在不同体系中转化的速度依次为：水溶液＞患者尿液＞正常人尿液。从海藻龙须菜中提取的硫酸多糖可以稳定COD的存在并减小COM的聚集，这有利于阻止草酸钙结石的形成，因此，海藻龙须菜多糖有可能用于防止草酸钙结石形成。     

快速溶剂萃取-离子色谱-质谱法测定人体血液、尿液中的氟乙酸

建立了快速溶剂萃取-离子色谱-质谱法测定人体血液、尿液中氟乙酸的方法。以去离子水为萃取溶剂，使用快速溶剂萃取仪处理血液和尿液样品，取上清液依次经超滤管和0.22μm水相针式滤膜净化，稀释50倍后进样检测。采用Ion Pac AS20离子色谱柱以15.0 mmol/L的KOH溶液为淋洗液进行等度淋洗，流出液通过抑制器后进入三重四极杆质谱，在负离子、多反应监测模式下检测，外标法定量。结果表明，氟乙酸在0.5～500.0μg/L范围内线性关系良好(r>0.999),检出限和定量限分别为0.14、0.47μg/L。氟乙酸在血液和尿液中的回收率分别为93.4%～95.8%、96.2%～98.4%,日内精密度分别为0.8%～1.6%、0.2%～1.0%,日间精密度分别为2.3%～3.8%、3.9%～6.9%。进一步考察发现该方法在血液、尿液中的基质效应较弱，分别为-7.4%、-3.0%。该法无需衍生化处理，简便高效，灵敏度高，重复性好，适用于人体血液、尿液中氟乙酸的快速检测。     

超高效液相色谱-串联质谱筛查确证尿液中磺胺、喹诺酮与四环素抗生素

建立了超高效液相色谱-串联质谱法（UPLC-MS/MS）同时测定尿液中磺胺类、四环素类、喹诺酮类共45种抗生素的检测方法。尿液样品经提取后，采用HLB固相萃取柱（200 mg/6 mL）净化，使用ThermoAccucore RP-MS(100 mm×2.1 mm,2.6μm)色谱柱进行分离，以乙腈-0.02%甲酸溶液为流动相梯度洗脱。在正离子扫描模式下（ESI+），以选择反应监测模式（SRM）检测，外标法定量。45种目标化合物在3个加标水平（2.0、5.0、10.0μg/L）下的回收率为78.6%～114%，相对标准偏差为0.60%～18%；方法的检出限为0.1～0.5μg/L，定量下限为0.3～1μg/L。将所建方法用于280个尿液样品中抗生素的检测，均未检测到抗生素残留。所建方法的精密度和准确度高，操作简单便捷，为尿液中抗生素残留的筛查提供了方法支持。     

黄芪口服液降低大鼠顺铂毒性作用机制的尿液代谢组学研究

采用基于液相色谱-飞行时间质谱联用(LC-TOF-MS)技术的代谢组学方法,分析大鼠尿液内源性代谢物的变化,研究黄芪口服液(HO)降低大鼠顺铂(CDDP)毒性的作用机制.采用低剂量多次腹腔注射CDDP的方法建立CDDP染毒大鼠模型,并连续给予16天HO.于第18天收集正常对照(Control)组、顺铂模型(CDDP)组和黄芪口服液(HO)组大鼠的24 h尿液, 进行LC-TOF-MS分析,以获取尿液代谢物组数据集,对所得数据进行主成分分析(PCA)和正交偏最小二乘法-判别分析(OPLS-DA)等多元统计分析,以筛选潜在生物标志物.于第20天采集大鼠血清测定肌酐和尿素氮水平.血清指标测定结果表明, HO可以显著降低CDDP染毒大鼠的肌酐和尿素氮水平(p<0.05).PCA得分图显示,3组可分别聚类,HO组位于Control组和CDDP组中间,表明HO可部分改善CDDP所致大鼠尿液代谢产物的异常变化.综合OPLS-DA分析、t检验和倍数变化分析结果,最终共筛选并初步鉴定出35个尿液代谢产物作为HO减毒相关的潜在生物标记物.代谢通路分析结果表明,HO可通过纠正体内氨基酸代谢、能量代谢和核苷酸代谢等通路的紊乱,降低CDDP所致机体毒性.     

液相色谱-串联质谱法测定尿液中的泛酸

该文建立了检测尿液中泛酸含量的液相色谱-串联质谱(HPLC-MS/MS)方法,尿液经过离心、稀释后,采用ACPUITY UPLC SS T3(2.1 mm×100 mm,1.8μm)色谱柱进行分离,电喷雾正离子模式电离,多反应监测模式进行检测,方法的线性关系良好(r=0.999 3),方法检出限为0.46 ng/m L,回收率为87.9%~95.3%,相对标准偏差(RSD)为2.5%~13.0%。该方法具有灵敏度高、分析时间短等特点,可用于尿液中泛酸含量的分析。     

同位素稀释气相色谱-质谱联用法监测芥子气染毒家兔尿液中的硫二甘醇

以硫二甘醇(TDG)的八氘代同位素(TDG-d8)为内标,采用自制Florisil固相萃取(SPE)柱提取尿样中的TDG,用五氟苯甲酰氯(PFBZ)衍生化后,再经SPE净化富集,通过考察优化两步固相萃取(SPE)等前处理步骤,建立了尿液中TDG的高灵敏同位素稀释-负化学电离-气相色谱/质谱(ID-NCI-GC/MS)分析方法。研究了家兔皮肤芥子气(HD)染毒(0.02~0.15 LD50)后,尿液中TDG随时间变化的时效关系及其与HD染毒剂量间的量效关系。结果显示,本方法的检出限为0.1μg/L,定量限为0.3μg/L;家兔染毒后尿液中TDG含量迅速升高,然后又快速减少,并呈现二次释放的特点;各剂量组在第1日内TDG排出量最多,且随着中毒剂量增高,尿液中高含量的TDG维持时间延长。因而,尿液中TDG的异常升高可以作为HD暴露的重要特征指标。     

人巨细胞病毒检测在婴幼儿肺炎中的应用

目的探讨HCMV检测在婴幼儿肺炎中的诊断价值和临床应用。方法对2013年1月—12月180例在呼伦贝尔市人民医院诊断为婴幼儿肺炎的患儿进行外周血HCMV-IgM和尿液HCMV-DNA的检测,分别采用酶联免疫捕获法(ELISA)、荧光定量聚合酶链反应(PCR)对收集的血清及尿液进行检测。结果 180例婴幼儿肺炎中确诊为HCMV感染的72例,其中54例血清HCMV-IgM检测阳性,阳性率占75%,62例尿液HCMV-DNA检测阳性,阳性率占86%。对检测出HCMV的患儿进行临床跟踪调查发现用更昔洛韦等药物治疗后疗效显著。结论婴幼儿肺炎中HCMV感染所占比率高,通过血清HCMV-IgM及尿液HCMV-DNA的联合检测能够给临床提供一个治疗依据,有助于早期诊断、早期治疗,对减少并发症及预后至关重要。     

中毒患者血清和尿液中毒鼠强残留物的GC-MS分析方法

有关资料表明,人和动物口服毒鼠强后,其血液、尿液和各脏器中均有毒鼠强残留物出现,残留时间从药后数小时至几天乃至十几天之内不等。可见血液和尿液作为可印证中毒病人中毒原因的直接样品更值得我们去关注,与呕吐物、可疑食物等检品相比,它具有提取相对简单,干扰成分少,残留时间长以及可反复采集等许多优点。因此,我们结合突发性中毒检验工作的需要,利用超声波液-液萃取技术,研究了中毒患者血清和尿液中毒鼠强残留物的GC-MS-SIM检测方法。在对40多人份血清和尿液添加标准物的反复测定中,回收率血清保持在90.8％～99.5％;RSD为3.82％,尿液保持在91.2％～102.8％,RSD为4.91％,全过程仅需约30min。经过两年来百多份样品检测的验证,该方法不失为日常快速分析中毒患者血清和尿液中毒鼠强残留物的一种有效方法,现介绍如下。     

Determination of thiols and disulfides in normal rat tissues and hamster pancreas treated with N-nitrosobis(2-oxopropyl)amine using 4-(aminosulfonyl)-7-fluoro-2,1,3-benzoxadiazole and ammonium 7-fluoro-2,1,3-benzoxadiazole-4-sulfonate

Biological thiols and disulfides in rat and hamster tissues were simultaneously determined by HPLC-fluorescence detection using 4-(aminosulfonyl)-7-fluoro-2,1,3-benzoxadiazole (ABD-F) and ammonium 7-fluoro-2,1,3-benzoxadiazole-4-sulfonate (SBD-F). The coefficients of variation (CV) of the method for reduced glutathione (GSH) and oxidized glutathione (GSSG) in liver and for cysteine (CySH) and cystine (CySSCy) in kidney were less than 3.1%. In 11 tissues of Wistar rats (liver, spleen, heart, lung, stomach, bladder, ovary, uterus, adrenal, kidney and pancreas), only CySH, CySSCy, GSH and/or GSSG were detected. Other thiols and disulfides were at extremely low levels in all samples. Both concentrations of CySH and CySSCy in the livers of old rats (111 weeks old, F344) were significantly higher than those of young rats (8 weeks old) (CySH, 0.246 +/- 0.099 vs 0.130 +/- 0.020 mumol/g; CySSCy, 0.051 +/- 0.027 vs 0.013 +/- 0.002 mumol/g). Administration of N-nitrosobis(2-oxopropyl)amine (BOP), a selective carcinogen of hamster pancreatic cancer, to Syrian golden hamsters (38 weeks old) resulted in the increase in the pancreas of GSH to a level 19 times as high and of GSSG to a level 14 times as high as those in untreated hamsters (GSH, 1.173 +/- 0.272 vs 0.062 +/- 0.017 mumol/g; GSSG, 0.155 +/- 0.063 vs 0.011 +/- 0.001 mumol/g).     

Characterization of urease derived from Citrullus lanatus (watermelon) seeds to estimate total Kjeldahl nitrogen in human urine

A urease extract prepared by decanting liquid from a suspension of finely ground Citrullus lanatus (watermelon) seeds was characterized and applied to dilute urine samples to demonstrate a low-cost field method to estimate total Kjeldahl nitrogen (TKN) concentrations in human urine. The extract exhibited a Michaelis-Menten constant, K_m, of 3.00 mM urea and a specific activity of up to 12.2 U/mg protein at an optimum pH of 8.1. A statistical F-test on 54 samples demonstrated that TKN can be estimated as the total ammonium-nitrogen recovered upon addition of urease in dilute fresh and stale urine samples. The total ammonium-nitrogen in urine samples determined after treatment with watermelon seed urease was consistent with that determined using traditional acid digestion techniques. The extract retained 85% of its initial capacity after three months of refrigeration. The effectiveness of this method to assay nitrogen in unbuffered urine samples will be useful in nitrogen analyses in nutrient recovery and urine or slurry storage contexts. Accordingly, this study is useful in understanding the kinetics of a plant-derived urease acting in dilute urine.     

Pharmacokinetics and pharmacodynamics of tetra(m-hydroxyphenyl)chlorin in the hamster cheek pouch tumor model: comparison with clinical measurements

The pharmacokinetics (PK) of the photosensitizer tetra(m-hydroxyphenyl)chlorin (mTHPC) was measured by optical fiber-based light-induced fluorescence spectroscopy (LIFS) in the normal and tumoral cheek pouch mucosa of 29 Golden Syrian hamsters with chemically induced squamous cell carcinoma. Similar measurements were carried out on the normal oral cavity mucosa of five patients up to 30 days after injection. The drug doses were between 0.15 and 0.3 mg per kg of body weight (mg/kg), and the mTHPC fluorescence in the tissue was excited at 420 nm. The PK in both human and hamster exhibited similar behavior although the PK in the hamster mucosa was slightly delayed in comparison with that of its human counterpart. The mTHPC fluorescence signal of the hamster mucosa was smaller than that of the human mucosa by a factor of about 3 for the same injected drug dose. A linear correlation was found between the fluorescence signal and the mTHPC dose in the range from 0.075 to 0.5 mg/kg at times between 8 and 96 h after injection. No significant selectivity in mTHPC fluorescence between the tumoral and normal mucosa of the hamsters was found at any of the applied conditions. The sensitivity of the normal and tumoral hamster cheek pouch mucosa to mTHPC photodynamic therapy as a function of the light dose was determined by light irradiation at 650 nm and 150 mW/cm2, 4 days after the injection of a drug dose of 0.15 mg/kg. These results were compared with irradiations of the normal oral and normal and tumoral bronchial mucosa of 37 patients under the same conditions. The reaction to PDT of both types of human mucosae was considerably stronger than that of the hamster cheek pouch mucosa. The sensitivity to PDT became comparable between hamster and human mucosa when the drug dose for the hamster was increased to 0.5 mg/kg. A significant therapeutic selectivity between the normal and neoplastic hamster cheek pouch was observed. Less selectivity was found following irradiations of normal mucosa and early carcinomas in the human bronchi. The pharmacodynamic behavior of mTHPC was determined by test irradiations of the normal mucosa of hamsters and patients between 6 h and 8 days after injection of 0.5 and 0.15 mg/kg in the hamsters and the patients, respectively. The normal hamster cheek pouch showed a maximum response to irradiation 6 h after injection and then decreased continuously to no observable reaction at 8 days after injection. The reaction of the normal human oral mucosa, however, showed an increasing sensitivity to the applied light between 6 h and 4 days after mTHPC injection and then decreased again at 8 days. The hamster model with the chemically induced early squamous cell cancer in the cheek pouch thus showed some similarity to the early squamous cell cancer of the human oral mucosa considering the PK. However, a quantitative difference in fluorescence signal for identical mTHPC doses as well as a significant difference in pharmacodynamic behavior were also observed. The suitability of this animal model for the optimization of PDT parameters in the clinic is therefore limited. Hence great care must be taken in screening new dyes for PDT of early squamous cell cancer of the upper aerodigestive tract based upon observables in the hamster cheek pouch model.     

Efficacy of Ficus spp. on renal injury induced by hypercholesterolaemia

The ethanol and hexane extracts of Ficus microcarpa, Ficus religiosa and Ficus mysorensis leaves were evaluated against renal injury induced by hypercholesterolaemia. Phytochemical screening of the investigated plants was undertaken. For the in vivo study, all rats were orally given cholesterol (30?mg?kg?1 body weight, BW) and leaves extract (500?mg?kg?1 BW) five times per week for 9 weeks. Hypercholesterolaemic rats showed significant increases in urea nitrogen and creatinine while serum protein and albumin levels, nitric oxide (NO), Na?-K?-ATPase and phospholipids in kidney tissue were all decreased. Treatment with leaves extract improved kidney function indices (urea nitrogen, creatinine, serum protein and albumin), kidney disorder biochemical parameters (NO, Na?-K?-ATPase and phospholipids), haematological profile (haemoglobin, RBCs and WBCs) and kidney histopathology. In conclusion, Ficus spp. succeeded in improving renal injury induced by hypercholesterolaemia, with the most potent effects seen while using Ficus microcarpa hexane extract.     

Glutathione and methylation of inorganic arsenic in hamsters

The effect of giutathione (GSH) concentrations in livers and kidneys of hamsters on the toxicity and methylation of arsenite in these animals was studied. No significant changes in hepatic and renal GSH concentrations were observed after a single arsenite administration (5 mg As kg^?1, p.o.). When buthionine sulfoximine (BSO), an inhibitor of GSH synthesis, was given (4 mmol kg^?1, i.p.) two hours before administration of arsenite, hepatic and renal GSH concentrations were more severely and persistently depressed than in the case of BSO administration not followed by arsenite. Hamsters treated with BSO plus arsenite suffered from severe nephrotoxicity (acute renal failure) characterized by increases in plasma creatinine and urea nitrogen and by proximal tubular necrosis. Concurrently, transient hepatotoxicity was observed in the BSO plus arsenite group. Neither arsenite alone nor BSO alone produced liver or kidney injury. The BSO plus arsenite-treated animals excreted in the urine only 3.5% of the arsenic dose during the 72 h period after administration of arsenite, probably because of a decrease in urine volume caused by kidney injury, whereas the arsenite-only group excreted 27%. In addition, BSO pretreatment influenced the relative proportion of arsenic metabolites excreted in the urine during the first 24 h after administration. Urinary metabolites in the BSO plus arsenite group were predominantly inorganic arsenic. These results suggest that GSH provides protection against arsenic toxicity.     

Modular Functionalization of Metal-Organic Frameworks for Nitrogen Recovery from Fresh Urine**

Nitrogen recovery from wastewater represents a sustainable route to recycle reactive nitrogen (Nr). It can reduce the demand of producing Nr from the energy-extensive Haber-Bosch process and lower the risk of causing eutrophication simultaneously. In this aspect, source-separated fresh urine is an ideal source for nitrogen recovery given its ubiquity and high nitrogen contents. However, current techniques for nitrogen recovery from fresh urine require high energy input and are of low efficiencies because the recovery target, urea, is a challenge to separate. In this work, we developed a novel fresh urine nitrogen recovery treatment process based on modular functionalized metal–organic frameworks (MOFs). Specifically, we employed three distinct modification methods to MOF-808 and developed robust functional materials for urea hydrolysis, ammonium adsorption, and ammonia monitoring. By integrating these functional materials into our newly developed nitrogen recovery treatment process, we achieved an average of 75 % total nitrogen reduction and 45 % nitrogen recovery with a 30-minute treatment of synthetic fresh urine. The nitrogen recovery process developed in this work can serve as a sustainable and efficient nutrient management that is suitable for decentralized wastewater treatment. This work also provides a new perspective of implementing versatile advanced materials for water and wastewater treatment.     

Study of the extraction process and in vivo inhibitory effect of ganoderma triterpenes in oral mucosa cancer

The aim of the reported study was to optimize the extraction process for ganoderma triterpenes and to investigate the in vivo inhibitory effect of ganoderma triterpenes on the genesis and progression of oral cancer. Single-factor and orthogonal methods were used to investigate the effects of extraction solvent, solvent amount, extraction time, extraction temperature, and number of extractions, on the extraction rate for ganoderma triterpenes. A golden hamster model with cheek pouch dynamic canceration was established to receive oral treatment of ganoderma triterpenes water solution. Animals were continuously monitored, oral tissue samples were collected for histopathologic examination, and changes in the expression of VEGF (vascular endothelial growth factor) and Caspase-3 were detected by immunohistochemical methods. Optimization of the experimental conditions allowed the identification of the optimal extraction conditions: 90% ethanol as the extraction solvent, a solvent amount by the liquid-material ratio of 35 mL/g, extraction time of 2 h and extraction temperature of 80 °C. Under these conditions, the average extraction rate of ganoderma triterpenes was 1.09%. Tests in golden hamsters showed that compared with the model group during the same period, animals in the treatment group had better conditions, constantly larger number of normal cases shown by histopathologic results (P < 0.01), and consistently smaller numbers of cases with paraplasm (P < 0.05). Immunohistochemical results showed that compared with the model group, the treatment group had significantly lower (P < 0.05) rates of positive VEGF expression in the normal state, simple epithelial hyperplasia, epithelial dysplasia or squamous cell carcinoma disease stages. Caspase-3 expression showed a tendency toward a gradual increase with the worsening of disease severity in each group. Compared with the model group, the treatment group had significantly lower (P < 0.05) rates of positive Caspase-3 in the normal state, simple epithelial hyperplasia, epithelial dysplasia or squamous cell carcinoma disease grades. Using the optimized extraction process, ganoderma triterpenes could be extracted with high efficiency, and the results of animal tests showed inhibitory effects of ganoderma triterpenes on oral mucosa cancer.     

UHPLC-MS-Based Serum and Urine Metabolomics Reveals the Anti-Diabetic Mechanism of Ginsenoside Re in Type 2 Diabetic Rats

Panax ginseng was employed in the treatment of “Xiao-Ke” symptom, which nowadays known as diabetes mellitus, in traditional Chinese medicine for more than a thousand years. Ginsenoside Re was the major pharmacologic ingredient found abundantly in ginseng. However, the anti-diabetic of Ginsenoside Re and its underlying mechanism in metabolic level are still unclear. Serum and urine metabolomic method was carried out to investigate the anti-diabetic pharmacological effects and the potential mechanism of Ginsenoside Re on high-fat diet combined streptozotocin-induced type 2 diabetes mellitus (T2DM) rats based on ultra-high-performance liquid chromatography coupled with quadrupole exactive orbitrap mass spectrometry (UHPLC-Q-Exactive Orbitrap/MS). Serum and urine samples were collected from the control group (CON), T2DM group, metformin (MET) treatment group, and ginsenoside Re treatment group after intervention. The biochemical parameters of serum were firstly analyzed. The endogenous metabolites in serum and urine were detected by UHPLC-MS. The potential metabolites were screened by multivariate statistical analysis and identified by accurate mass measurement, MS/MS, and metabolite databases. The anti-diabetic-related metabolites were analyzed by KEGG metabolic pathway, and its potential mechanism was discussed. The treatment of ginsenoside Re significantly reduced the blood glucose and serum lipid level improved the oxidative stress caused by T2DM. Biochemical parameters (urea nitrogen, uric acid) showed that ginsenoside Re could improve renal function in T2DM rats. Respective 2 and 6 differential metabolites were found and identified in serum and urine of ginsenoside Re compared with T2DM group and enriched in KEGG pathway. Metabolic pathways analysis indicated that the differential metabolites related to T2DM were mainly involved in arachidonic acid metabolism, Vitamin B6, steroid hormone biosynthesis, and bile secretion metabolic pathways. This study verified the anti-diabetic and anti-oxidation effects of ginsenoside Re, elaborated that ginsenoside Re has a good regulation of the metabolic disorder in T2DM rats, which could promote insulin secretion, stimulated cannabinoid type 1 receptor (CB₁), and CaMKK β to activate AMPK signaling pathway, inhibited insulin resistance, and improved blood glucose uptake and diabetic nephropathy, so as to play the role of anti-diabetic.     

聚鲁米诺-金属离子复合物膜的电化学发光特性及其分析应用研究

建立了一种基于电聚合和配位效应构建聚鲁米诺-金属离子复合物膜修饰电极测定尿素的电化学发光分析新方法, 并且提出了一种优化聚鲁米诺电化学发光分析特性的新思路. 在最佳条件下, 增敏电化学发光信号与尿素的质量浓度在2.0×10-9—1.0×10-7 g/mL 范围内呈线性关系, 检出限为1.7×10-10 g/mL.